185 related articles for article (PubMed ID: 34415404)
1. Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma.
Lenz JA; Assenmacher CA; Costa V; Louka K; Rau S; Keuler NS; Zhang PJ; Maki RG; Durham AC; Radaelli E; Atherton MJ
Cancer Immunol Immunother; 2022 Apr; 71(4):807-818. PubMed ID: 34415404
[TBL] [Abstract][Full Text] [Related]
2. PTPN11 mutations in canine and human disseminated histiocytic sarcoma.
Hédan B; Rault M; Abadie J; Ulvé R; Botherel N; Devauchelle P; Copie-Bergman C; Cadieu E; Parrens M; Alten J; Zalcman EL; Cario G; Damaj G; Mokhtari K; Le Loarer F; Coulomb-Lhermine A; Derrien T; Hitte C; Bachelot L; Breen M; Gilot D; Blay JY; Donadieu J; André C
Int J Cancer; 2020 Sep; 147(6):1657-1665. PubMed ID: 32212266
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.
Hedan B; Thomas R; Motsinger-Reif A; Abadie J; Andre C; Cullen J; Breen M
BMC Cancer; 2011 May; 11():201. PubMed ID: 21615919
[TBL] [Abstract][Full Text] [Related]
4. T Lymphocytes in Histiocytic Sarcomas of Flat-Coated Retriever Dogs.
Marcinowska A; Constantino-Casas F; Williams T; Hoather T; Blacklaws B; Dobson J
Vet Pathol; 2017 Jul; 54(4):605-610. PubMed ID: 28129095
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases expression in spontaneous canine histiocytic sarcomas and its xenograft model.
Fayyad A; Lapp S; Risha E; Pfankuche VM; Rohn K; Barthel Y; Schaudien D; Baumgärtner W; Puff C
Vet Immunol Immunopathol; 2018 Apr; 198():54-64. PubMed ID: 29571518
[TBL] [Abstract][Full Text] [Related]
6. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
Affolter VK; Moore PF
Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
[TBL] [Abstract][Full Text] [Related]
7. Clinical prognostic factors in canine histiocytic sarcoma.
Dervisis NG; Kiupel M; Qin Q; Cesario L
Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy.
Latifi M; Tuohy JL; Coutermarsh-Ott SL; Klahn SL; Leeper H; Dervisis N
J Vet Intern Med; 2020 Nov; 34(6):2645-2650. PubMed ID: 32986268
[TBL] [Abstract][Full Text] [Related]
9. Morphological Distinction of Histiocytic Sarcoma from Other Tumor Types in Bernese Mountain Dogs and Flatcoated Retrievers.
Erich SA; Constantino-Casas F; Dobson JM; Teske E
In Vivo; 2018; 32(1):7-17. PubMed ID: 29275293
[TBL] [Abstract][Full Text] [Related]
10. Identification of common predisposing loci to hematopoietic cancers in four dog breeds.
Hédan B; Cadieu É; Rimbault M; Vaysse A; Dufaure de Citres C; Devauchelle P; Botherel N; Abadie J; Quignon P; Derrien T; André C
PLoS Genet; 2021 Apr; 17(4):e1009395. PubMed ID: 33793571
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.
Asada H; Tomiyasu H; Okada K; Chambers JK; Goto-Koshino Y; Uchida K; Kagawa Y; Ohno K; Tsujimoto H
Res Vet Sci; 2019 Jun; 124():57-60. PubMed ID: 30852355
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
13. A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma.
Asada H; Tsuboi M; Chambers JK; Uchida K; Tomiyasu H; Goto-Koshino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2017 Oct; 79(10):1721-1726. PubMed ID: 28867679
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs.
Ruple A; Morley PS
J Vet Intern Med; 2016 Jul; 30(4):1197-203. PubMed ID: 27160025
[TBL] [Abstract][Full Text] [Related]
15. A review of histiocytic diseases of dogs and cats.
Moore PF
Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.
Thaiwong T; Sirivisoot S; Takada M; Yuzbasiyan-Gurkan V; Kiupel M
Vet Comp Oncol; 2018 Jun; 16(2):220-228. PubMed ID: 28929581
[TBL] [Abstract][Full Text] [Related]
17. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells.
Yamazaki H; Takagi S; Hosoya K; Okumura M
Vet J; 2015 Sep; 205(3):375-80. PubMed ID: 26048444
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma.
Prouteau A; Denis JA; De Fornel P; Cadieu E; Derrien T; Kergal C; Botherel N; Ulvé R; Rault M; Bouzidi A; François R; Dorso L; Lespagnol A; Devauchelle P; Abadie J; André C; Hédan B
Sci Rep; 2021 Jan; 11(1):877. PubMed ID: 33441840
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma.
Hirabayashi M; Chambers JK; Kishimoto TE; Nguyen SV; Ishikawa Y; Rimpo K; Nakayama H; Uchida K
Vet Comp Oncol; 2022 Jun; 20(2):465-475. PubMed ID: 34907644
[TBL] [Abstract][Full Text] [Related]
20. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers.
Elliott J
Aust Vet J; 2018 Dec; 96(12):502-507. PubMed ID: 30478839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
